Increased apoptosis in TSC mutant versus wild-type cells suggests that these drugs can be a promising therapy option for disease control, since it would selectively kill tumor cells, while non-tumor and non-stressed cells would be able to cope to transient stress. Here, TSC1 is linked to neoplasm.